Login / Signup

Investigation of Atyp.C using UF-5000 flow cytometer in patients with a suspected diagnosis of urothelial carcinoma: a single-center study.

Chunyun RenXing WangChunwei YangShengchao LiShuangchun LiuHongcui Cao
Published in: Diagnostic pathology (2020)
It is worth knowing and reporting that the Atyp.C assay may be used as an accessory test for patients with suspected urothelial carcinoma, based on its ability to identify high-risk patients who might need closer follow-up or additional medical treatment.
Keyphrases
  • healthcare
  • high throughput
  • pulmonary embolism
  • adverse drug
  • combination therapy